Conditions: Open-angle Glaucoma Ocular Hypertension
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 15
Healthy volunteers: no

Brief summary:
This study will evaluate the efficacy and safety of brimonidine 0.1% three-times daily in patients with glaucoma or ocular hypertension

Detailed description:

Arms:
arm 1: brimonidine 0.1%

Interventions: intervention 1: brimonidine 0.1% (Alphagan® P)
Intervention descriptions: intervention 1: Brimonidine 0.1%, 1 drop three-times daily for 4 weeks

Protocol document: